These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 37994701)
1. A novel HPV16 splicing enhancer critical for viral oncogene expression and cell immortalization. Jönsson J; Wang L; Kajitani N; Schwartz S Nucleic Acids Res; 2024 Jan; 52(1):316-336. PubMed ID: 37994701 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region. Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322 [TBL] [Abstract][Full Text] [Related]
3. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35). McFarlane M; MacDonald AI; Stevenson A; Graham SV J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103 [TBL] [Abstract][Full Text] [Related]
4. hnRNP G/RBMX enhances HPV16 E2 mRNA splicing through a novel splicing enhancer and inhibits production of spliced E7 oncogene mRNAs. Hao C; Zheng Y; Jönsson J; Cui X; Yu H; Wu C; Kajitani N; Schwartz S Nucleic Acids Res; 2022 Apr; 50(7):3867-3891. PubMed ID: 35357488 [TBL] [Abstract][Full Text] [Related]
5. E6^E7, a novel splice isoform protein of human papillomavirus 16, stabilizes viral E6 and E7 oncoproteins via HSP90 and GRP78. Ajiro M; Zheng ZM mBio; 2015 Feb; 6(1):e02068-14. PubMed ID: 25691589 [TBL] [Abstract][Full Text] [Related]
6. High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation. Zheng Y; Li X; Jiao Y; Wu C Front Cell Infect Microbiol; 2022; 12():929666. PubMed ID: 35832386 [TBL] [Abstract][Full Text] [Related]
7. Intron definition and a branch site adenosine at nt 385 control RNA splicing of HPV16 E6*I and E7 expression. Ajiro M; Jia R; Zhang L; Liu X; Zheng ZM PLoS One; 2012; 7(10):e46412. PubMed ID: 23056301 [TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells. He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257 [TBL] [Abstract][Full Text] [Related]
9. The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. Tang S; Tao M; McCoy JP; Zheng ZM J Virol; 2006 May; 80(9):4249-63. PubMed ID: 16611884 [TBL] [Abstract][Full Text] [Related]
10. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins. Harden ME; Prasad N; Griffiths A; Munger K mBio; 2017 Jan; 8(1):. PubMed ID: 28049151 [TBL] [Abstract][Full Text] [Related]
11. HnRNP D activates production of HPV16 E1 and E6 mRNAs by promoting intron retention. Cui X; Hao C; Gong L; Kajitani N; Schwartz S Nucleic Acids Res; 2022 Mar; 50(5):2782-2806. PubMed ID: 35234917 [TBL] [Abstract][Full Text] [Related]
12. Transforming Properties of Beta-3 Human Papillomavirus E6 and E7 Proteins. Minoni L; Romero-Medina MC; Venuti A; Sirand C; Robitaille A; Altamura G; Le Calvez-Kelm F; Viarisio D; Zanier K; Müller M; Accardi R; Tommasino M mSphere; 2020 Jul; 5(4):. PubMed ID: 32669468 [TBL] [Abstract][Full Text] [Related]
13. The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture. Sedman SA; Barbosa MS; Vass WC; Hubbert NL; Haas JA; Lowy DR; Schiller JT J Virol; 1991 Sep; 65(9):4860-6. PubMed ID: 1651408 [TBL] [Abstract][Full Text] [Related]
14. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3. Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046 [TBL] [Abstract][Full Text] [Related]
15. Different HPV16 E6/E7 oncogene expression patterns in epithelia reconstructed from HPV16-immortalized human endocervical cells and genital keratinocytes. Sun Q; Tang SC; Pater MM; Pater A Oncogene; 1997 Nov; 15(20):2399-408. PubMed ID: 9395236 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system. Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665 [TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic poly(A) binding proteins regulate telomerase activity and cell growth in human papillomavirus type 16 E6-expressing keratinocytes. Katzenellenbogen RA; Vliet-Gregg P; Xu M; Galloway DA J Virol; 2010 Dec; 84(24):12934-44. PubMed ID: 20943973 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of genes involved in keratinocyte differentiation by human papillomavirus 16 oncoproteins. Gyöngyösi E; Szalmás A; Ferenczi A; Póliska S; Kónya J; Veress G Arch Virol; 2015 Feb; 160(2):389-98. PubMed ID: 25488293 [TBL] [Abstract][Full Text] [Related]
19. Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18. Díaz-Tejeda Y; Guido-Jiménez MC; López-Carbajal H; Amador-Molina A; Méndez-Martínez R; Gariglio-Vidal P; Lizano M; García-Carrancá A Viruses; 2021 Jul; 13(8):. PubMed ID: 34452350 [TBL] [Abstract][Full Text] [Related]
20. Coordinated action of human papillomavirus type 16 E6 and E7 oncoproteins on competitive endogenous RNA (ceRNA) network members in primary human keratinocytes. László B; Antal L; Gyöngyösi E; Szalmás A; Póliska S; Veress G; Kónya J BMC Cancer; 2021 Jun; 21(1):673. PubMed ID: 34098875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]